Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ATOS Atossa Therapeutics
- 1.1200
- -0.0300-2.61%
Close Dec 13 16:00 ET
- 1.1197
- -0.0003-0.03%
Post 20:01 ET
140.90MMarket Cap-5.33P/E (TTM)
1.1600High1.0700Low1.20MVolume1.1500Open1.1500Pre Close1.32MTurnover1.01%Turnover RatioLossP/E (Static)125.80MShares2.310052wk High1.91P/B132.12MFloat Cap0.701352wk Low--Dividend TTM117.97MShs Float2231.9981Historical High--Div YieldTTM7.83%Amplitude0.5000Historical Low1.1040Avg Price1Lot Size
Atossa Therapeutics News
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7
Atossa Therapeutics Analyst Ratings
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4
Atossa Therapeutics Is Maintained at Buy by Ascendiant Capital
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4
Atossa Therapeutics Analyst Ratings
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Raises Target Price to $7
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4
Atossa Therapeutics Analyst Ratings
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $6
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $6
Atossa Therapeutics Analyst Ratings
Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4
Atossa Therapeutics Analyst Ratings
Atossa Therapeutics Analyst Ratings
Atossa Therapeutics Analyst Ratings
Atossa Therapeutics' Endoxifen Shows Promising Phase 2 Results, Secures Buy Rating
Atossa Therapeutics Analyst Ratings
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.